- ADVM Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
10-K/A Filing
Adverum Biotechnologies (ADVM) 10-K/A2018 FY Annual report (amended)
Filed: 29 Apr 19, 9:38pm
Exhibit 31.4
CERTIFICATION
PURSUANT TO SECTION 302 OF
THE SARBANES-OXLEY ACT OF 2002
I, Thomas Leung, certify that:
1. | I have reviewed this Form10-K/A of Adverum Biotechnologies, Inc.; and |
2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report. |
Date: April 30, 2019
By: | /s/ Thomas Leung | |||
Name: | Thomas Leung | |||
Title: | Chief Financial Officer | |||
(Principal Financial and Accounting Officer) |
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.